Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates.
Saved in:
| Title: | Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates. |
|---|---|
| Authors: | Pena ES; Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA., Ontiveros-Padilla L; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Lukesh NR; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Williamson GL; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Murphy CT; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Hendy DA; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Roque JA 3rd; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Carlock MA; Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL, USA., Ross TM; Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL, USA; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, USA.; Department of Infection Biology, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA., Ainslie KM; Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ainsliek@email.unc.edu., Bachelder EM; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Aug 10; Vol. 384, pp. 113936. Date of Electronic Publication: 2025 Jun 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40482923 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pena+ES%22">Pena ES</searchLink>; Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ontiveros-Padilla+L%22">Ontiveros-Padilla L</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Lukesh+NR%22">Lukesh NR</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Williamson+GL%22">Williamson GL</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Murphy+CT%22">Murphy CT</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Hendy+DA%22">Hendy DA</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Roque+JA+3rd%22">Roque JA 3rd</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA.<br /><searchLink fieldCode="AU" term="%22Carlock+MA%22">Carlock MA</searchLink>; Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL, USA.<br /><searchLink fieldCode="AU" term="%22Ross+TM%22">Ross TM</searchLink>; Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL, USA; Center for Vaccines and Immunology, University of Georgia, Athens, GA, USA; Department of Infectious Diseases, University of Georgia, Athens, GA, USA.; Department of Infection Biology, Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Ainslie+KM%22">Ainslie KM</searchLink>; Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, NC, USA; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ainsliek@email.unc.edu.<br /><searchLink fieldCode="AU" term="%22Bachelder+EM%22">Bachelder EM</searchLink>; Division of Pharmacoengineering & Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2025 Aug 10; Vol. 384, pp. 113936. <i>Date of Electronic Publication: </i>2025 Jun 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40482923 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jconrel.2025.113936 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 113936 Titles: – TitleFull: Optimizing delivery in a multivalent subunit influenza vaccine using mixed polymeric microparticle degradation rates. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pena ES – PersonEntity: Name: NameFull: Ontiveros-Padilla L – PersonEntity: Name: NameFull: Lukesh NR – PersonEntity: Name: NameFull: Williamson GL – PersonEntity: Name: NameFull: Murphy CT – PersonEntity: Name: NameFull: Hendy DA – PersonEntity: Name: NameFull: Roque JA 3rd – PersonEntity: Name: NameFull: Carlock MA – PersonEntity: Name: NameFull: Ross TM – PersonEntity: Name: NameFull: Ainslie KM – PersonEntity: Name: NameFull: Bachelder EM IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 08 Text: 2025 Aug 10 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1873-4995 Numbering: – Type: volume Value: 384 Titles: – TitleFull: Journal of controlled release : official journal of the Controlled Release Society Type: main |
| ResultId | 1 |
